AT348132B - Verfahren zur herstellung einer tablette fuer medizinische zwecke - Google Patents

Verfahren zur herstellung einer tablette fuer medizinische zwecke

Info

Publication number
AT348132B
AT348132B AT848175A AT848175A AT348132B AT 348132 B AT348132 B AT 348132B AT 848175 A AT848175 A AT 848175A AT 848175 A AT848175 A AT 848175A AT 348132 B AT348132 B AT 348132B
Authority
AT
Austria
Prior art keywords
tablet
manufacturing
medical purposes
medical
purposes
Prior art date
Application number
AT848175A
Other languages
English (en)
Other versions
ATA848175A (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority claimed from FR7534965A external-priority patent/FR2331327A2/fr
Publication of ATA848175A publication Critical patent/ATA848175A/de
Application granted granted Critical
Publication of AT348132B publication Critical patent/AT348132B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
AT848175A 1975-11-17 1975-11-07 Verfahren zur herstellung einer tablette fuer medizinische zwecke AT348132B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7534965A FR2331327A2 (fr) 1972-01-13 1975-11-17 Composition medicamenteuse solide a desagregation rapide

Publications (2)

Publication Number Publication Date
ATA848175A ATA848175A (de) 1978-06-15
AT348132B true AT348132B (de) 1979-01-25

Family

ID=9162473

Family Applications (1)

Application Number Title Priority Date Filing Date
AT848175A AT348132B (de) 1975-11-17 1975-11-07 Verfahren zur herstellung einer tablette fuer medizinische zwecke

Country Status (6)

Country Link
AT (1) AT348132B (de)
AU (1) AU507575B2 (de)
BE (1) BE835572A (de)
DE (1) DE2549740A1 (de)
GB (1) GB1504553A (de)
NL (1) NL7513230A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
US4783334A (en) * 1986-01-21 1988-11-08 Chugai Seiyaku Kabushiki Kaisha Stable solid preparation of thiol ester derivative
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
EP0580860B2 (de) * 1991-04-16 2004-12-15 Nippon Shinyaku Company, Limited Verfahren zur herstellung einer festen dispersion
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
AU3574500A (en) * 1999-03-25 2000-10-16 Yuhan Corporation Rapidly disintegrable tablet for oral administration
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water

Also Published As

Publication number Publication date
GB1504553A (en) 1978-03-22
DE2549740A1 (de) 1977-05-18
ATA848175A (de) 1978-06-15
AU8651675A (en) 1977-05-19
NL7513230A (nl) 1977-05-16
AU507575B2 (en) 1980-02-21
BE835572A (fr) 1976-05-13

Similar Documents

Publication Publication Date Title
AT364077B (de) Verfahren zur herstellung einer pharmazeutischen zubereitung fuer die enterale applikation
AT353415B (de) Verfahren zur herstellung eines pharma- zeutischen praeparates
LU78996A1 (de) Verfahren zur herstellung von fungiziden mitteln
DD137710A5 (de) Verfahren zur herstellung neuer 1-acyl-2-cyanaziridine
AT347578B (de) Verfahren zur herstellung einer neuen arzneimittelzubereitung
AT348132B (de) Verfahren zur herstellung einer tablette fuer medizinische zwecke
ATA713376A (de) Verfahren zur herstellung eines rektal anwendbaren pharmazeutischen praparates
ATA251777A (de) Verfahren zur herstellung vorstellung von acrylnitril
AT361140B (de) Verfahren zur herstellung optisch aktiver 11- -desoxy-16-aryloxy-omega-tetranorprostaglandine
AT343276B (de) Verfahren zur herstellung einer antiviral wirksamen pharmazeutischen zusammensetzung
DD128590A5 (de) Verfahren zur herstellung optisch aktiver 11-desoxy-16-aryl-omega-tetranorprostaglandine
AT369987B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT346319B (de) Verfahren zur herstellung kernalkylierter mehrkernphenole
ATA392577A (de) Verfahren zur herstellung von acylcyaniden
AT350181B (de) Verfahren zur herstellung einer mischvaccine
AT348670B (de) Verfahren zur herstellung von cephalosporin- tabletten
DD130144A5 (de) Verfahren zur herstellung von benzoylcyanid
DD130240A5 (de) Verfahren zur herstellung von acylcyaniden
DD136837A5 (de) Verfahren zur herstellung pharmazeutisch wirksamer pteridin-verbindungen
LU79769A1 (de) Verfahren zur herstellung von naphtalincarbonsaeureestern
ATA504577A (de) Verfahren zur herstellung einer arzneimittelzubereitung zur aeusserlichen anwendung
DD138774A5 (de) Verfahren zur herstellung neuer piperazinopyrrolobenzodiazepinen
DD138330A5 (de) Verfahren zur herstellung von fructose
DD128852A5 (de) Verfahren zur herstellung neuer d-homosteroide
PT65800B (de) Verfahren zur herstellung einer pharmazeutischen zubereitung

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee